Pulmonary paracoccidioidomycosis : a case report of reactivation in a patient receiving biological therapy
Paracoccidioidomycosis is an endemic disease in Latin America that is rarely associated with immunosuppression and biological therapy. Herein, we report for the first time a case of pulmonary paracoccidioidomycosis reactivation after infliximab treatment. A 47-year-old man from Brazil received infliximab to treat psoriatic spondyloarthropathy and presented with cough, dyspnea, weight loss, and fever. Chest computed tomography revealed a pulmonary nodule and biopsy confirmed paracoccidioidomycosis. Treatment with sulfamethoxazole and trimethoprim was initiated for fungal infection and infliximab was reintroduced two months later. Considering his clinical improvement and favorable radiologic evolution, antifungal therapy was discontinued after 29 months.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2018 |
---|---|
Erschienen: |
2018 |
Enthalten in: |
Zur Gesamtaufnahme - volume:51 |
---|---|
Enthalten in: |
Revista da Sociedade Brasileira de Medicina Tropical - 51(2018), 2 vom: 14. März, Seite 249-252 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Covre, Lúcia Carla Polaco [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 24.05.2018 Date Revised 24.05.2018 published: Print Citation Status MEDLINE |
---|
doi: |
10.1590/0037-8682-0222-2017 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM284148423 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM284148423 | ||
003 | DE-627 | ||
005 | 20231225042536.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2018 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1590/0037-8682-0222-2017 |2 doi | |
028 | 5 | 2 | |a pubmed24n0947.xml |
035 | |a (DE-627)NLM284148423 | ||
035 | |a (NLM)29768566 | ||
035 | |a (PII)S0037-86822018000200249 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Covre, Lúcia Carla Polaco |e verfasserin |4 aut | |
245 | 1 | 0 | |a Pulmonary paracoccidioidomycosis |b a case report of reactivation in a patient receiving biological therapy |
264 | 1 | |c 2018 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 24.05.2018 | ||
500 | |a Date Revised 24.05.2018 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Paracoccidioidomycosis is an endemic disease in Latin America that is rarely associated with immunosuppression and biological therapy. Herein, we report for the first time a case of pulmonary paracoccidioidomycosis reactivation after infliximab treatment. A 47-year-old man from Brazil received infliximab to treat psoriatic spondyloarthropathy and presented with cough, dyspnea, weight loss, and fever. Chest computed tomography revealed a pulmonary nodule and biopsy confirmed paracoccidioidomycosis. Treatment with sulfamethoxazole and trimethoprim was initiated for fungal infection and infliximab was reintroduced two months later. Considering his clinical improvement and favorable radiologic evolution, antifungal therapy was discontinued after 29 months | ||
650 | 4 | |a Case Reports | |
650 | 7 | |a Antirheumatic Agents |2 NLM | |
650 | 7 | |a Infliximab |2 NLM | |
650 | 7 | |a B72HH48FLU |2 NLM | |
700 | 1 | |a Hombre, Pâmela Mazzini |e verfasserin |4 aut | |
700 | 1 | |a Falqueto, Aloísio |e verfasserin |4 aut | |
700 | 1 | |a Peçanha, Paulo Mendes |e verfasserin |4 aut | |
700 | 1 | |a Valim, Valéria |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Revista da Sociedade Brasileira de Medicina Tropical |d 1993 |g 51(2018), 2 vom: 14. März, Seite 249-252 |w (DE-627)NLM012655953 |x 1678-9849 |7 nnns |
773 | 1 | 8 | |g volume:51 |g year:2018 |g number:2 |g day:14 |g month:03 |g pages:249-252 |
856 | 4 | 0 | |u http://dx.doi.org/10.1590/0037-8682-0222-2017 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 51 |j 2018 |e 2 |b 14 |c 03 |h 249-252 |